Basal and dynamic proinsulin-insulin relationship to assess β-cell function during OGTT in metabolic disorders

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 1 48-1, 2003, Pages

  Tura, Andrea ^a   Pacini, Giovanni ^a   Kautzky Willer, Alexandra ^b   Ludvik, Bernhard ^b   Prager, Rudolf ^b   Thomaseth, Karl ^a  

^a CNR   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Impaired glucose tolerance; Mathematical modeling; Proinsulin clearance; Proinsulin secretion; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN;

ADULT; ARTICLE; CALCULATION; CELL DAMAGE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DYNAMICS; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN CLEARANCE; INSULIN RELEASE; KINETICS; MATHEMATICAL MODEL; MEASUREMENT; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; TASK PERFORMANCE;

EID: 0038001564     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00104.2002     Document Type: Article

References (24)

1. Afifi AA and Azen SP. Statistical Analysis - A Computer Oriented Approach. New York: Academic, 1979.
2. Ahrén B and Pacini G. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol Endocrinol Metab 273: E701-E707, 1997.
3. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i: 307-310, 1986.
4. Carson ER, Cobelli C, and Finkelstein L. The Mathematical Modeling of Metabolic and Endocrine Systems. New York: Wiley, 1983.
5. Clodi M, Thomaseth K, Pacini G, Hermann K, Kautzky-Willer A, Waldhäusl W, Prager R, and Ludvik B. Distribution and kinetics of amylin in humans. Am J Physiol Endocrinol Metab 274: E903-E908, 1998.
6. Cobelli C and Pacini G. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes 37: 223-232, 1988.
7. Docherty K and Steiner DF. Molecular and cellular biology of the beta cell. In: Diabetes Mellitus, edited by Porte D Jr and Sherwin RS. London: Prentice-Hall, 1997, p. 29-48.
8. Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Browsher RR, and Andersom JH. Biosynthetic human proinsulin. Diabetes Care 15: 666-692, 1992.
9. Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, and Prager R. β-Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41: 1304-1312, 1992.
10. Kautzky-Willer A, Prager R, Waldhäusl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, and Ludvik B. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20: 1717-1723, 1997.
11. Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhäusl W, Pacini G, and Prager R. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46: 607-614, 1997.
12. Nagamatsu S, Bolaffi JL, and Grodsky GM. Direct effects of glucose on proinsulin synthesis and processing during desensitization. Endocrinology 120: 1225-1231, 1987.
13. Pacini G. Mathematical models of insulin secretion in physiological and clinical investigations. Comput Methods Programs Biomed 41: 269-285, 1994.
14. Rhodes CJ and Halban PA. Newly synthesized proinsulin/ insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol 105: 145-153, 1987.
15. Stumvoll M, Fritsche A, Stefan N, Hardt E, and Häring H. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and β-cell dysfunction. J Clin Endocrinol Metab 86: 1235-1239, 2001.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197, 1997.
17. Thomaseth K. A modeling tool for biomedical systems. Simulation Practice and Theory [Online]. Elsevier. http://www.elsevier. nl/locate/simpra[2001].
18. Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, and Pacini G. Integrated mathematical model to assess β-cell activity during the oral glucose test. Am J Physiol Endocrinol Metab 270: E522-E531, 1996.
19. Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, and Ludvik B. Amylin release during oral glucose tolerance test. Diabet Med 14: S29-S34, 1997.
20. Tura A, Ludvik B, Nolan JJ, Pacini G, and Thomaseth K. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab 281: E966-E974, 2001.
21. Volund A, Polonsky KS, and Bergman RN. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes 36: 1195-1202, 1987.
22. Wang P, Abbasi F, Carantoni M, Chen YI, Azhar S, and Reaven GM. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers. J Clin Endocrinol Metab 82: 3221-3224, 1997.
23. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, and Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702, 1987.
24. Zilker TR, Gray IP, Hales CN, Wahl K, Ermler R, Lebender A, Heinzel G, and Bottermann P. Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers. Horm Metab Res Suppl 18: 37-43, 1988.